Company intelligence / Profile preview

Marine Colloids Canada

Dartmouth, Nova Scotia, Canada

Ownership: Private
Development stage: Other

Overview

Marine Colloids Canada was a specialized manufacturer of seaweed-derived hydrocolloids, primarily carrageenan, which is used extensively in the pharmaceutical and healthcare sectors. The company focused on the extraction of biopolymers from marine sources to create stabilizing, thickening, and gelling agents essential for drug formulation and delivery systems. Originally part of the Marine Colloids division, it became a cornerstone of FMC Corporation's BioPolymer business unit after its acquisition. Through subsequent industry consolidation, the business was transferred to DuPont and eventually merged into IFF (International Flavors & Fragrances), where its legacy products continue to serve the global pharma excipient market.

Modalities: ExcipientsPolymers
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Marine Colloids Canada.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marine Colloids Canada.

Explore the full profile